141 related articles for article (PubMed ID: 34661166)
1. Within Host Dynamics of SARS-CoV-2 in Humans: Modeling Immune Responses and Antiviral Treatments.
Ghosh I
SN Comput Sci; 2021; 2(6):482. PubMed ID: 34661166
[TBL] [Abstract][Full Text] [Related]
2. Dynamical demeanour of SARS-CoV-2 virus undergoing immune response mechanism in COVID-19 pandemic.
Mondal J; Samui P; Chatterjee AN
Eur Phys J Spec Top; 2022; 231(18-20):3357-3370. PubMed ID: 35075384
[TBL] [Abstract][Full Text] [Related]
3. Global Dynamics of SARS-CoV-2 Infection with Antibody Response and the Impact of Impulsive Drug Therapy.
Chatterjee AN; Basir FA; Biswas D; Abraha T
Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366355
[TBL] [Abstract][Full Text] [Related]
4. Human Nasal and Lung Tissues Infected
Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
[TBL] [Abstract][Full Text] [Related]
5. A simple in-host model for COVID-19 with treatments: model prediction and calibration.
Al-Darabsah I; Liao KL; Portet S
J Math Biol; 2023 Jan; 86(2):20. PubMed ID: 36625956
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
mBio; 2020 May; 11(3):. PubMed ID: 32444382
[TBL] [Abstract][Full Text] [Related]
7. Modeling viral dynamics in SARS-CoV-2 infection based on differential equations and numerical analysis.
Odaka M; Inoue K
Heliyon; 2021 Oct; 7(10):e08207. PubMed ID: 34693064
[TBL] [Abstract][Full Text] [Related]
8. Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cells.
Bernhauerová V; Lisowski B; Rezelj VV; Vignuzzi M
J Theor Biol; 2021 Dec; 531():110895. PubMed ID: 34499915
[TBL] [Abstract][Full Text] [Related]
9. The molecular mechanism of SARS-CoV-2 evading host antiviral innate immunity.
Gu W; Gan H; Ma Y; Xu L; Cheng ZJ; Li B; Zhang X; Jiang W; Sun J; Sun B; Hao C
Virol J; 2022 Mar; 19(1):49. PubMed ID: 35305698
[TBL] [Abstract][Full Text] [Related]
10. Innate immunity plays a key role in controlling viral load in COVID-19: mechanistic insights from a whole-body infection dynamics model.
Dogra P; Ruiz-Ramírez J; Sinha K; Butner JD; Peláez MJ; Rawat M; Yellepeddi VK; Pasqualini R; Arap W; Sostman HD; Cristini V; Wang Z
medRxiv; 2020 Nov; ():. PubMed ID: 33173913
[TBL] [Abstract][Full Text] [Related]
11. Within-host delay differential model for SARS-CoV-2 kinetics with saturated antiviral responses.
Dehingia K; Das A; Hincal E; Hosseini K; El Din SM
Math Biosci Eng; 2023 Nov; 20(11):20025-20049. PubMed ID: 38052635
[TBL] [Abstract][Full Text] [Related]
12. Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2.
Chen N; Zhang B; Deng L; Liang B; Ping J
Emerg Microbes Infect; 2022 Dec; 11(1):1371-1389. PubMed ID: 35476817
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel mathematical model that explains SARS-CoV-2 infection dynamics in Caco-2 cells.
Staroverov V; Nersisyan S; Galatenko A; Alekseev D; Lukashevich S; Polyakov F; Anisimov N; Tonevitsky A
PeerJ; 2023; 11():e14828. PubMed ID: 36748087
[TBL] [Abstract][Full Text] [Related]
14. Mathematical modeling of COVID-19 transmission: the roles of intervention strategies and lockdown.
Bugalia S; Bajiya VP; Tripathi JP; Li MT; Sun GQ
Math Biosci Eng; 2020 Sep; 17(5):5961-5986. PubMed ID: 33120585
[TBL] [Abstract][Full Text] [Related]
15. Mathematical modeling of viral infection dynamics and immune response in SARS-CoV-2: A computational framework for testing drug efficacy.
Sharma S; Saxena A; Chel S; Mitra K; Giri L
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():4370-4373. PubMed ID: 34892188
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of SARS-CoV-2 infection model with two modes of transmission and immune response.
Hattaf K; Yousfi N
Math Biosci Eng; 2020 Aug; 17(5):5326-5340. PubMed ID: 33120555
[TBL] [Abstract][Full Text] [Related]
17. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 viral dynamics in non-human primates.
Gonçalves A; Maisonnasse P; Donati F; Albert M; Behillil S; Contreras V; Naninck T; Marlin R; Solas C; Pizzorno A; Lemaitre J; Kahlaoui N; Terrier O; Ho Tsong Fang R; Enouf V; Dereuddre-Bosquet N; Brisebarre A; Touret F; Chapon C; Hoen B; Lina B; Rosa Calatrava M; de Lamballerie X; Mentré F; Le Grand R; van der Werf S; Guedj J
PLoS Comput Biol; 2021 Mar; 17(3):e1008785. PubMed ID: 33730053
[TBL] [Abstract][Full Text] [Related]
19. Modelling of the Innate and Adaptive Immune Response to SARS Viral Infection, Cytokine Storm and Vaccination.
Leon C; Tokarev A; Bouchnita A; Volpert V
Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36679972
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.
Yang W; Shaman J
medRxiv; 2021 Nov; ():. PubMed ID: 34845460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
